114 Views
Monday Poster Session
Category: Esophagus
Sara Ghoneim, MD
University of Nebraska Medical Center
Omaha, NE, United States
Study and year | Country | No. Centers | Date of study | Sample Size for analysis | No. Patients exclude from analysis | Average age (Years) | Gender distribution (M/F) | Reference standard | PPI dose | Duration |
Randomized Controlled Trial | ||||||||||
Schenk et al. 2007 | Netherlands | Multi-center | July 1993- July 1994 | 85 | 13 | Omeprazole: 49 Placebo: 49 | 33/52 | pH-metry Endoscopy | Omeprazole 40 mg daily | 2 weeks |
Juul-Hansen et al. 2001 | Norway | Single center | NA | 64 | 0 | 54 | 20/44 | pH-metry Endoscopy | Lansoprazole 60 mg daily | 5 days |
Open label Trials | ||||||||||
Troche et al. 2005 | Mexico | Single center | NA | 64 | 1 | 39.3 | 17/47 | pH-metry Endoscopy | Rabeprazole 20 mg BID | 1 week |
Cho et al. 2010 | Korea | Single center | NA | 73 | 0 | 47 | 40/37 | pH-metry Endoscopy | Lansoprazole 30 mg BID | 2 weeks |
Fass et al. 2000 | United States | Single center | NA | 35 | 1 | 55 | 33/2 | pH-metry Endoscopy | Omeprazole 40 mg AM 20 mg before dinner | 1 week |